Genius Sports Limited [GENI] stock Resumed by Citigroup analyst, price target now $9

Genius Sports Limited [NYSE: GENI] gained 17.20% on the last trading session, reaching $9.47 price per share at the time.

If compared to the average trading volume of 2.42M shares, GENI reached a trading volume of 11024435 in the most recent trading day, which is why market watchdogs consider the stock to be active.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Here is what top equities market gurus are saying about Genius Sports Limited [GENI]:

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for GENI shares is $10.12 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on GENI stock is a recommendation set at 1.15. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

Citigroup have made an estimate for Genius Sports Limited shares, keeping their opinion on the stock as Buy, with their previous recommendation back on June 13, 2024. While these analysts kept the previous recommendation, Goldman raised their target price to Buy. The new note on the price target was released on April 16, 2024, representing the official price target for Genius Sports Limited stock. Previously, the target price had yet another raise to $9, while B. Riley Securities analysts kept a Buy rating on GENI stock.

The Average True Range (ATR) for Genius Sports Limited is set at 0.42, with the Price to Sales ratio for GENI stock in the period of the last 12 months amounting to 4.89. The Price to Book ratio for the last quarter was 3.62, with the Price to Cash per share for the same quarter was set at 0.41. Price to Free Cash Flow for GENI in the course of the last twelve months was 403.96 with Quick ratio for the last quarter at 1.54.

Trading performance analysis for GENI stock

Genius Sports Limited [GENI] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 39.47. With this latest performance, GENI shares gained by 21.41% in over the last four-week period, additionally plugging by 78.68% over the last 6 months – not to mention a rise of 79.70% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for GENI stock in for the last two-week period is set at 79.08, with the RSI for the last a single of trading hit 86.66, and the three-weeks RSI is set at 73.13 for Genius Sports Limited [GENI]. The present Moving Average for the last 50 days of trading for this stock 7.53, while it was recorded at 8.05 for the last single week of trading, and 6.45 for the last 200 days.

Genius Sports Limited [GENI]: A deeper dive into fundamental analysis

Genius Sports Limited’s liquidity data is similarly interesting compelling, with a Quick Ratio of 1.54 and a Current Ratio set at 1.54.

An analysis of Institutional ownership at Genius Sports Limited [GENI]

The top three institutional holders of GENI stocks are: CALEDONIA (PRIVATE) INVESTMENTS PTY LTD with ownership of 20.15 million shares, which is approximately 8.7883%. GRANAHAN INVESTMENT MANAGEMENT, LLC, holding 9.97 million shares of the stock with an approximate value of $$54.32 million in GENI stocks shares; and GRANAHAN INVESTMENT MANAGEMENT, LLC, currently with $$45.28 million in GENI stock with ownership which is approximately 3.6232%.